Another study showed that TREM-1+ TAMs in HCC induce immunosuppression by recruiting C-C chemokine receptor type 6-positive Treg cells, releasing CCL20 and producing the immune checkpoint molecule PD-L1 which may endow HCC with anti-PD-L1 therapy resistance (41). This evidence concerns the gene TREM1 and hepatocellular carcinoma.